MLL3 promotes the senescence of esophageal squamous cell carcinoma
Authors Xia M, Ling F, Gao F, Tao C
Received 14 September 2018
Accepted for publication 17 January 2019
Published 1 March 2019 Volume 2019:12 Pages 1575—1582
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Andrew Yee
Peer reviewer comments 2
Editor who approved publication: Dr Leo Jen-Liang Su
Manhui Xia,1,* Feng Ling,2,* Feng Gao,1 Chunmu Tao2
1Department of Thoracic Surgery, Jingjiang People’s Hospital of Jiangsu Province, Jingjiang City 214500, Jiangsu Province, China; 2Department of Gastroenterology, Jingjiang People’s Hospital of Jiangsu Province, Jingjiang City 214500, Jiangsu Province, China
*These authors contributed equally to this work
Background: Senescence has been recognized as a mechanism for the suppression of tumorigenesis. However, how the senescence is regulated is not fully understood.
Aims: The present study aims to elucidate MLL3-mediated regulation of senescence.
Materials and methods: MLL3 protein levels in esophageal squamous cell carcinoma (ESCC) tissues were examined by Western blotting and immunohistochemistry. The effects of MLL3 on the growth and senescence of ESCC cells were examined using MTT assay, soft agar assay, and β-gal staining. The interaction between MLL3 and P16 was evaluated by immunoprecipitation and GST pull-down assay.
Results: In this study, we found that MLL3 promoted the senescence of ESCC cells. MLL3 was downregulated in ESCC. MLL3 inhibited the growth and colony formation of ESCC cells. Mechanistically, MLL3 interacted with P16 and impaired the interaction between P16 and UHRF1 (the E3 ligase for P16), thus upregulating the protein levels of several senescence regulators.
Conclusion: Collectively, this study demonstrated the regulation of senescence by MLL3.
Keywords: ESCC, MLL3, senescence, P16
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]